Quarterly Result5 Feb 2026, 05:22 pm
Suraksha Diagnostic Reports 30.3% Y-o-Y Growth in Q3 FY26 Total Income
AI Summary
Suraksha Diagnostic Limited, the largest integrated diagnostic chain in East India, announced its unaudited financial results for the quarter and nine months ended 31 December 2025. The company reported a 30.3% year-on-year growth in total income in Q3 FY26, with EBITDA growing by 26.1% year-on-year. The company added 12 operational centers in 9M FY26 and forayed into the high-value genomics segment with Suraksha Sutra. Despite the launch and development of new centers, the company's centers older than 2 years maintain a strong 37% EBITDA margin.
Key Highlights
- Suraksha Diagnostic reported a 30.3% Y-o-Y growth in total income in Q3 FY26.
- EBITDA grew by 26.1% year-on-year in Q3 FY26.
- In 9M FY26, the company added 12 operational centers and 6 centers are under development.
- The company forayed into the high-value genomics segment with Suraksha Sutra.
- Centers older than 2 years maintain a strong 37% EBITDA margin despite the launch and development of new centers.